Fecal microbiota transplant (FMT) has drawn intense interest as a way to treat disease, by adjusting our microbial makeup to harbor more “good” and fewer “bad” bacteria. Based on successful treatment of Clostridium difficile infections, FMT is now being looked at for a wide range of conditions.

The microbiome is thought to influence not only GI infection and disease, but also cancer, neurologic diseases, autism, obesity, metabolic diseases, psychiatric diseases, respiratory diseases and atherosclerosis. More than 200 FMT studies are currently registered on ClinicalTrials.gov, including several dozen pediatric studies. …Read More